ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,010,000 | +98.4% | 24,383 | +247.6% | 0.06% | +121.4% |
| Q1 2022 | $509,000 | +83.8% | 7,015 | +113.2% | 0.03% | +180.0% |
| Q4 2021 | $277,000 | -52.4% | 3,290 | -49.0% | 0.01% | -66.7% |
| Q3 2021 | $582,000 | -52.3% | 6,448 | -49.6% | 0.03% | -42.3% |
| Q2 2021 | $1,221,000 | +127.0% | 12,801 | +95.7% | 0.05% | -10.3% |
| Q3 2020 | $538,000 | +151.4% | 6,542 | +138.6% | 0.06% | +61.1% |
| Q2 2020 | $214,000 | -34.2% | 2,742 | -62.5% | 0.04% | -7.7% |
| Q1 2020 | $325,000 | +18.6% | 7,316 | +69.7% | 0.04% | +62.5% |
| Q2 2019 | $274,000 | – | 4,311 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |